Patent intelligence · US
US 9267151
STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness
STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness
Patent details — US 9267151
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 23, 2016
- Expiration
- Feb 18, 2036
- Claims
- 10
- CPC classes
- A61P, A61P25/00, A61P25/18
Quick answer
US 9267151 (STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness) is held by UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA. Status: granted. Granted Feb 23, 2016. Expires Feb 18, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61P, A61P25/00, A61P25/18
More from UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA
Related pharmaceutical patents in our USPTO index.
-
US 12226429
Highly active compounds against COVID-19
granted -
US 12084473
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 12006340
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
granted -
US 12005139
Ophthalmic formulations and related methods
granted -
US 11975016
2′-substituted-N6-substituted purine nucleotides for RNA virus treatment
granted -
US 11964047
Ophthalmic formulations and related methods
granted -
US 11833160
Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases
granted -
US 11813278
Highly active compounds against COVID-19
granted
Frequently asked questions
What is US patent 9267151?
US 9267151 (STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness) is held by UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA. Status: granted. Granted Feb 23, 2016. Expires Feb 18, 2036 (10 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9267151?
UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 35 pharmaceutical patents for this assignee.
When does US 9267151 expire?
Our index shows an expiration date of Feb 18, 2036 (10 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.